On 6 January 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) licensed the new dosage of Wegovy, which is three times higher than the previously available 2.4mg dose for weight loss
Combination with Insulin with or without Metformin In a 26-week double blind trial (Trial 6, NCT03021187), 731 adult patients with type 2 diabetes mellitus inadequately controlled on insulin (basal, basal/bolus or premixed) with or without metformin, were randomized to RYBELSUS 3 mg, 7 mg and 14 mg once daily or placebo once daily
25 Jan How Semaglutide Compares to Other Weight Loss Medications Obesity is a growing problem in the United States, with over 42% of adults classified as obese
Combining all these helps in managing blood sugar levels and reduces body weight
However, tirzepatide also costs more